×
About 1,768 results

ALLMedicine™ Peripartum Cardiomyopathy Center

Research & Reviews  827 results

The HGR motif is the antiangiogenic determinant of vasoinhibin: implications for a ther...
https://doi.org/10.1007/s10456-021-09800-x 10.1038/nm0603-653 10.1016/S0140-6736(15)01088-0 10.1016/j.cell.2019.01.021 10.1016/j.biopha.2018.12.022 10.1186/s13045-019-0718-5 10.1038/nrc2442 10.1038/aps.2015.73 10.1158/0008-5472.CAN-04-2427 10.1016/s1357-2725(01)00023-1 10.2174/138920111796117300 10.1016/j.bmc.2017.06.052 10.1152/physrev.00024.2009 10.1007/978-3-319-12114-7_4 10.1038/nm.3552 10.1152/ajpregu.00256.2015 10.1002/iub.518 10.1167/tvst.9.9.27 10.1038/pr.2016.241 10.1016/j.cell.2006.12.036 10.1038/labinvest.3700662 10.1038/s41374-020-0432-5 10.1016/j.pep.2019.04.011 10.1016/j.tem.2006.08.002 10.1038/s41598-018-35383-7 10.1007/s12038-011-9073-6 10.1016/S1046-5928(02)00639-3 10.1016/s0022-2836(03)00367-x 10.1002/jcc.20291 10.1016/j.jmb.2005.06.042 10.1038/nprot.2007.54 10.1073/pnas.0712168105 10.1038/nprot.2007.30 10.1186/gb-2006-7-10-r100 10.3791/51046 10.1007/978-1-4939-3628-1_9 10.1038/s41598-020-67289-8 10.1007/978-1-59745-241-0_17 10.1007/s10456-012-9324-7 10.1111/jne.12858 10.1167/iovs.11-8190 10.1038/sj.mt.6300294 10.1073/pnas.96.4.1246 10.1167/iovs.10-5176 10.3389/fncel.2014.00333 10.1172/JCI34508 10.1021/acs.chemrev.6b00838 10.1016/S0140-6736(16)00559-6 10.1073/pnas.0606638103 10.1016/j.ygcen.2011.12.033 10.1016/j.febslet.2005.04.005 10.1093/nar/gkx1085 10.1073/pnas.0803241105 10.1038/s41598-018-33911-z 10.1016/j.ab.2016.06.025 10.1093/eurheartj/ehx355 10.3389/fendo.2018.00242
Angiogenesis Robles JP, Zamora M et. al.

Jun 7th, 2021 - The hormone prolactin acquires antiangiogenic and antivasopermeability properties after undergoing proteolytic cleavage to vasoinhibin, an endogenous prolactin fragment of 123 or more amino acids that inhibits the action of multiple proangiogenic ...

Perhexiline treatment improves toxic effects of β-adrenergic receptor stimulation in ex...
https://doi.org/10.1002/ehf2.13412
ESC Heart Failure; Pfeffer TJ, List M et. al.

May 18th, 2021 - Peripartum cardiomyopathy (PPCM) is a pregnancy-associated cardiomyopathy that occurs in previously heart-healthy women towards the end of pregnancy or in the first months after delivery and is characterized by heart failure due to systolic dysfun...

Elusive Diagnosis of Eosinophilic Myocarditis: A Case Series.
https://doi.org/10.1016/j.cpcardiol.2021.100849
Current Problems in Cardiology; Almusawi H, daSilva-deAbreu A et. al.

May 17th, 2021 - We present 2 relevant cases of eosinophilic myocarditis (EM) in patients that presented with cardiogenic shock, one of whom received a durable ventricular assist device followed by heart transplantation, with the diagnosis of EM being made based o...

Myocardial Damage in an Elderly Female Patient With Peripartum Cardiomyopathy.
https://doi.org/10.1253/circj.CJ-21-0148
Circulation Journal : Official Journal of the Japanese Ci... Kawano H, Matsumura K et. al.

May 13th, 2021 - Myocardial Damage in an Elderly Female Patient With Peripartum Cardiomyopathy.|2021|Kawano H,Matsumura K,Sueyoshi E,Koga S,Ikeda S,|

Intersection of Heart Failure and Pregnancy: Beyond Peripartum Cardiomyopathy.
https://doi.org/10.1161/CIRCHEARTFAILURE.120.008223
Circulation. Heart Failure; DeFilippis EM, Haythe JH et. al.

May 13th, 2021 - Heart failure (HF) is a leading cause of morbidity and mortality in pregnant women in the United States. Although peripartum cardiomyopathy is the most common diagnosis for pregnant women with HF, women with preexisting cardiomyopathies and systol...

see more →

Guidelines  1 results

Current state of knowledge on aetiology, diagnosis, management, and therapy of peripart...
https://doi.org/10.1093/eurjhf/hfq120
European Journal of Heart Failure; Sliwa K, Hilfiker-Kleiner D et. al.

Aug 2nd, 2010 - Peripartum cardiomyopathy (PPCM) is a cause of pregnancy-associated heart failure. It typically develops during the last month of, and up to 6 months after, pregnancy in women without known cardiovascular disease. The present position statement of...

see more →

Clinicaltrials.gov  875 results

The HGR motif is the antiangiogenic determinant of vasoinhibin: implications for a ther...
https://doi.org/10.1007/s10456-021-09800-x 10.1038/nm0603-653 10.1016/S0140-6736(15)01088-0 10.1016/j.cell.2019.01.021 10.1016/j.biopha.2018.12.022 10.1186/s13045-019-0718-5 10.1038/nrc2442 10.1038/aps.2015.73 10.1158/0008-5472.CAN-04-2427 10.1016/s1357-2725(01)00023-1 10.2174/138920111796117300 10.1016/j.bmc.2017.06.052 10.1152/physrev.00024.2009 10.1007/978-3-319-12114-7_4 10.1038/nm.3552 10.1152/ajpregu.00256.2015 10.1002/iub.518 10.1167/tvst.9.9.27 10.1038/pr.2016.241 10.1016/j.cell.2006.12.036 10.1038/labinvest.3700662 10.1038/s41374-020-0432-5 10.1016/j.pep.2019.04.011 10.1016/j.tem.2006.08.002 10.1038/s41598-018-35383-7 10.1007/s12038-011-9073-6 10.1016/S1046-5928(02)00639-3 10.1016/s0022-2836(03)00367-x 10.1002/jcc.20291 10.1016/j.jmb.2005.06.042 10.1038/nprot.2007.54 10.1073/pnas.0712168105 10.1038/nprot.2007.30 10.1186/gb-2006-7-10-r100 10.3791/51046 10.1007/978-1-4939-3628-1_9 10.1038/s41598-020-67289-8 10.1007/978-1-59745-241-0_17 10.1007/s10456-012-9324-7 10.1111/jne.12858 10.1167/iovs.11-8190 10.1038/sj.mt.6300294 10.1073/pnas.96.4.1246 10.1167/iovs.10-5176 10.3389/fncel.2014.00333 10.1172/JCI34508 10.1021/acs.chemrev.6b00838 10.1016/S0140-6736(16)00559-6 10.1073/pnas.0606638103 10.1016/j.ygcen.2011.12.033 10.1016/j.febslet.2005.04.005 10.1093/nar/gkx1085 10.1073/pnas.0803241105 10.1038/s41598-018-33911-z 10.1016/j.ab.2016.06.025 10.1093/eurheartj/ehx355 10.3389/fendo.2018.00242
Angiogenesis Robles JP, Zamora M et. al.

Jun 7th, 2021 - The hormone prolactin acquires antiangiogenic and antivasopermeability properties after undergoing proteolytic cleavage to vasoinhibin, an endogenous prolactin fragment of 123 or more amino acids that inhibits the action of multiple proangiogenic ...

Perhexiline treatment improves toxic effects of β-adrenergic receptor stimulation in ex...
https://doi.org/10.1002/ehf2.13412
ESC Heart Failure; Pfeffer TJ, List M et. al.

May 18th, 2021 - Peripartum cardiomyopathy (PPCM) is a pregnancy-associated cardiomyopathy that occurs in previously heart-healthy women towards the end of pregnancy or in the first months after delivery and is characterized by heart failure due to systolic dysfun...

Elusive Diagnosis of Eosinophilic Myocarditis: A Case Series.
https://doi.org/10.1016/j.cpcardiol.2021.100849
Current Problems in Cardiology; Almusawi H, daSilva-deAbreu A et. al.

May 17th, 2021 - We present 2 relevant cases of eosinophilic myocarditis (EM) in patients that presented with cardiogenic shock, one of whom received a durable ventricular assist device followed by heart transplantation, with the diagnosis of EM being made based o...

Myocardial Damage in an Elderly Female Patient With Peripartum Cardiomyopathy.
https://doi.org/10.1253/circj.CJ-21-0148
Circulation Journal : Official Journal of the Japanese Ci... Kawano H, Matsumura K et. al.

May 13th, 2021 - Myocardial Damage in an Elderly Female Patient With Peripartum Cardiomyopathy.|2021|Kawano H,Matsumura K,Sueyoshi E,Koga S,Ikeda S,|

Intersection of Heart Failure and Pregnancy: Beyond Peripartum Cardiomyopathy.
https://doi.org/10.1161/CIRCHEARTFAILURE.120.008223
Circulation. Heart Failure; DeFilippis EM, Haythe JH et. al.

May 13th, 2021 - Heart failure (HF) is a leading cause of morbidity and mortality in pregnant women in the United States. Although peripartum cardiomyopathy is the most common diagnosis for pregnant women with HF, women with preexisting cardiomyopathies and systol...

see more →

News  63 results

Fast Five Quiz: Can You Confront Heart Failure?
https://reference.medscape.com/viewarticle/842156_2

Oct 5th, 2020 - Specific underlying factors cause various forms of heart failure, such as systolic heart failure (most commonly, left ventricular [LV] systolic dysfunction), heart failure with preserved left ventricular ejection fraction (LVEF), acute heart failu...

Jan 10, 2020 This Week in Cardiology Podcast
https://www.staging.medscape.com/viewarticle/923581

Jan 9th, 2020 - For the week ending Jan 10 2020, John Mandrola, MD comments on the following cardiology news [and features] stories: CRF Commissions Review of Controversial EXCEL Trial The Unholy Pairing of Cancer and Peripartum Cardiomyopathy First-time Marathon...

Jan 10, 2020 This Week in Cardiology Podcast
https://www.medscape.com/viewarticle/923581

Jan 9th, 2020 - For the week ending Jan 10 2020, John Mandrola, MD comments on the following cardiology news [and features] stories: CRF Commissions Review of Controversial EXCEL Trial The Unholy Pairing of Cancer and Peripartum Cardiomyopathy First-time Marathon...

The Unholy Pairing of Cancer and Peripartum Cardiomyopathy
https://www.medscape.com/viewarticle/923470

Jan 6th, 2020 - New research bolsters a connection between the risk for cancer before and after peripartum cardiomyopathy (PPCM) and identifies genetic variants underlying PPCM and a variety of cancers. "This study is the first to describe a markedly increased ri...

The Unholy Pairing of Cancer and Peripartum Cardiomyopathy
https://www.staging.medscape.com/viewarticle/923470

Jan 6th, 2020 - New research bolsters a connection between the risk for cancer before and after peripartum cardiomyopathy (PPCM) and identifies genetic variants underlying PPCM and a variety of cancers. "This study is the first to describe a markedly increased ri...

see more →

Patient Education  2 results see all →